Juan Luis
Gómez Sirvent
Investigador en el periodo 1992-2022
Hospital Regional Universitario de Málaga
Málaga, EspañaPublicaciones en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (7)
2020
-
Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)
Scientific Reports, Vol. 10, Núm. 1
2019
-
ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in Spain
Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1763-1770
2016
-
Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV–HCV co-infected patients: final results of the Spanish BOC HIV–HCV Study
International Journal of Infectious Diseases, Vol. 53, pp. 46-51
2015
-
Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: The RELAX study
HIV Medicine, Vol. 16, Núm. 10, pp. 628-634
-
Renal safety of coformulated tenofovir/emtricitabine vs other nucleoside analogues in combination therapy in antiretroviral-naive patients aged 50 years or older in Spain: The TRIP study
HIV Clinical Trials, Vol. 16, Núm. 1, pp. 43-48
2014
-
Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: A multicentre experience in antiretroviral therapy-naive and -experienced patients
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 9
2013
-
Safety, efficacy, and persistence of emtricitabine/tenofovir versus other nucleoside analogues in naive subjects aged 50 years or older in Spain: The TRIP study
HIV Clinical Trials, Vol. 14, Núm. 5, pp. 204-215